TEVA PHARMACEUTICAL INDUSTRIES LIMITED Available-for-sale Securities, Amortized Cost Basis
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) had Available-for-sale Securities, Amortized Cost Basis of $103.00 million as of 2017-12-31, per its 10-K filed 2019-02-19.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2019-02-19
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $103.00M.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $164.00M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $282.00M.
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $304.00M.
| Period end | Available-for-sale Securities, Amortized Cost Basis |
|---|---|
| 2017-12-31 | $103.00M 10-K · filed 2019-02-19 |
| 2017-09-30 | $164.00M 6-K · filed 2017-11-02 |
| 2017-06-30 | $282.00M 6-K · filed 2017-08-03 |
| 2017-03-31 | $304.00M 6-K · filed 2017-05-11 |
| 2016-12-31 | $985.00M 10-K · filed 2018-02-12 |
| 2016-09-30 | $1.30B 6-K · filed 2016-11-15 |
| 2016-06-30 | $1.44B 6-K · filed 2016-08-04 |
| 2016-03-31 | $1.28B 6-K · filed 2016-05-09 |
| 2015-12-31 | $1.30B 20-F · filed 2017-02-15 |
| 2014-12-31 | $266.00M 20-F · filed 2016-02-11 |
| 2013-12-31 | $213.00M 20-F · filed 2015-02-09 |
| 2012-12-31 | $533.00M 20-F · filed 2014-02-10 |
| 2011-12-31 | $836.00M 20-F · filed 2013-02-12 |
| 2010-12-31 | $639.00M 20-F · filed 2012-02-17 |
| 2009-12-31 | $949.00M 20-F · filed 2011-02-15 |